Results 121 to 130 of about 22,545,234 (252)
Metrnl: A Novel Therapeutic Target in Atherosclerosis
ABSTRACT Atherosclerosis is a chronic inflammatory vascular disease and the main pathological basis of cardiovascular and cerebrovascular events. Exploration of endogenous protective factors in the disease is beneficial for the establishment of new therapeutic strategies.
Pin Wang, Dao‐Xin Wang, Chao‐Yu Miao
wiley +1 more source
Hodgkin's disease in an elderly patient with B-Cell chronic lymphocytic leukemia [PDF]
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia worldwide. It is an indolent disease, almost exclusively of B-cell origin. Some CLLs evolve into a more aggressive lymphoid malignancy.
Zafer Akcali +3 more
core +1 more source
Using 18 global databases, this country‐level ecological study identified major positive and negative correlates of multiple myeloma prevalence and death rate, providing hypothesis‐generating evidence to inform future public health research and policy development.
Peng Xu +8 more
wiley +1 more source
In 246 Korean patients with mature B‐cell neoplasms, ancestry‐informed PRS analysis using the 1000 Genomes East Asian population as an external reference showed only a modest overall case–reference difference. In contrast, phenotype‐matched PRS revealed the clearest and most consistent polygenic association in multiple myeloma, highlighting the ...
Youngeun Lee +4 more
wiley +1 more source
ABSTRACT Introduction Hepatocellular carcinoma (HCC) remains a major cause of cancer‐related mortality worldwide, and postoperative recurrence continues to limit long‐term survival. Liver‐resident natural killer (NK) cells are key effectors of antitumor immunity in the hepatic microenvironment. Interleukin‐37 (IL‐37), an anti‐inflammatory cytokine, has
Yuki Imaoka +10 more
wiley +1 more source
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia
p53 status and CD38 antigen are biological factors influencing response to therapy and clinical course in B-cell chronic lymphocytic leukemia (B-CLL). This study tests the hypothesis that soluble p53 alone and in association with CD38 can enucleate B-CLL
Marini, R +18 more
core +1 more source
Plasma Cell Mucositis: A 20‐Year Retrospective Review at a Tertiary Center
ABSTRACT Background Plasma cell mucositis (PCM) is a rare, chronic inflammatory condition of mucosal surfaces that is likely underdiagnosed and underreported, with limited data on its clinical characteristics, extracavitary involvement, and treatment outcomes.
Miguel A. Aristizabal‐Torres +4 more
wiley +1 more source
Unveiling MLLT3: A Key Transcription Factor in ESCC Prognosis and Immune Infiltration
ABSTRACT The transcription factor Myeloid/lymphoid or mixed‐lineage leukemia; translocated to, 3 (MLLT3) super elongation complex subunit plays an important role in the regulation of oncogenes and suppressor genes during cancer progression; however, how they participate in the occurrence and development of esophageal squamous cell carcinoma (ESCC) has ...
Shuolei Li, Yashu Zhang, Yongtao Bai
wiley +1 more source
Rheumatoid arthritis and B-cell chronic lymphocytic leukemia.
The association between lymphoproliferate malignancies, especially lymphoma, and rheumatoid arthritis (RA) has been confirmed by several studies. However; there are few reports of RA patients who developed B-cell chronic lymphocytic leukemia (B-CLL) and vice versa. We report a patient with B-CLL who developed RA and another with RA who presented with B-
Voulgari, P. V. +4 more
openaire +2 more sources
SHP2 in Cancer: From Tumor Biology to Therapeutic Targeting
ABSTRACT SHP2 is a tyrosine phosphatase that mediates intracellular signaling downstream of transmembrane receptors regulated by a pair of src homology 2 (SH2) domains. Its overexpression and mutation are pivotal in driving tumor progression by influencing various cancer's fundamental characteristics, such as metastasis, DNA repair, angiogenesis ...
Maryam Jama +2 more
wiley +1 more source

